1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CRISPR THERAPEUTICS AG
CRISPR Therapeutics AG XNAS: CRSP

CRISPR Therapeutics AG Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Read More
56.18 0.88 (1.59%)
28.41% Fall from 52W High
1.5M
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
10.7 / 100
Momentum Score
Technically Neutral
53.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
83
1Yr Price target upside is 49%
24 analysts

10

S

10

W

4

O

1

T

SWOT Analysis

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..